The EPi-Sense™ Guided Coagulation Device with VisiTrax®The EPi-Sense™ Guided Coagualtion Device with VisiTrax® combines the features of the Numeris™ device with first-of-its kind epicardial sensing electrodes designed to allow both EPs and cardiothoracic surgeons to map and navigate the epicardium. |
Embedded electrodes on the |
The EPi-Sense™ further enhances the advantages of the Convergent Procedure with the utilization of EP mapping for ablation on the epicardium of the atrium and ventricle. This device is believed to be the first ablation tool designed for hybrid use by surgeons and EPs for various arrhythmia procedures. Additionally, the new embedded sensing electrodes indicate when the EPi-Sense™ is in contact with cardiac tissue, which assures the heating element, in certain difficult to reach spots, is directed into the heart. EPi-Sense™ has received CE Mark approval for the treatment of cardiac arrhythmias including atrial fibrillation. The EPi-Sense™ system will be commercially available throughout Europe in Q4 of 2011.